Guardant Health

US · GH #820 by market cap Listed 2018

168.33 -2.36 -1.38%

Live - 5344 symbols - heartbeat 197s ago · 2026-10-08 07:03

Pre-market 168.33 0.00%

After-hours 168.33 0.00%

Overnight 167.98 -0.21%

Market cap: 22.59B
P/E (TTM): -47.96
P/B: -101.34
EPS: -3.32
Div yield: 0.00%
52W pos: 83%

Reader sentiment Are you bullish or bearish on GH?

Anonymous reader poll. Unscientific, not investment advice.

About Guardant Health

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Founded: 2011
CEO: Mr. Helmy Eltoukhy
Employees: 2,506
Headquarters: Palo Alto, California, United States of America
Fiscal year end: 12-31
Website: guardanthealth.com

Company profile

Exchange: US
Symbol: GH
Market-cap rank: #820
Listing date: 2018-10-04
Market cap: 22.59B
Float cap: 21.80B
Shares out: 134.20M
Float shares: 129.48M

Sectors & themes

Diagnostics & Research ARK Portfolio AI medical concept stocks Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 07:03:28 · For reference only, not investment advice and not tailored to your situation.